查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1848564

心臟瓣膜修復和置換設備市場：2025-2032 年全球預測（按置換和修復設備）

Heart Valve Repair & Replacement Devices Market by Replacement Devices, Repair Devices - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟瓣膜修復和置換設備市場將成長至 127 億美元，複合年成長率為 8.44%。

主要市場統計數據
基準年2024年 66.4億美元
預計2025年 72億美元
預測年份：2032年 127億美元
複合年成長率（%） 8.44%

全面介紹影響心臟瓣膜修復和置換術的不斷發展的臨床、技術和商業性動態

心臟瓣膜修復與置換術領域正處於外科傳統與快速導管創新交會的關鍵曲折點。影像學、器械設計和圍手術全期管理方面的進步正在逐步改變臨床決策路徑，並為不同頻譜的患者提供更廣泛的治療選擇。這項發展反映了心血管治療領域的更廣泛變化，包括多學科心臟團隊、更完善的患者選擇標準，以及對瓣膜長期表現和生活品質的重視。

如今，臨床醫生和醫療保健系統不僅會評估瓣膜介入治療的急性手術成功率，還會考慮其耐久性、再次介入的必要性以及對未來經導管治療的影響。因此，技術開發商和器材製造商優先考慮模組化、易於部署以及與瓣中瓣策略的兼容性。同時，監管機構和支付方也越來越關注真實世界證據和比較有效性，從而決定了瓣膜介入治療的商業化和報銷路徑。

綜合起來，這些因素共同構成了一個動態格局，臨床需求、技術能力和商業性需求相互作用。相關人員若能理解這些動態，並協調其產品開發、臨床證據產生和打入市場策略，將最有能力影響治療途徑，並抓住治療模式轉變帶來的機會。

臨床創新、診斷影像的進步以及實證商業化如何改變心臟瓣膜的治療方式和途徑

過去幾年發生了一場革命性的轉變，徹底改變了臨床醫師治療心臟瓣膜疾病的方式。微創經導管技術已從一種小眾選擇發展成為針對特定患者群體的主流治療方法，這得益於輸送系統、密封機制和器械外形的改進，這些改進減少了手術創傷並縮短了恢復時間。同時，血管假體的改進，包括組織處理和血流動力學最佳化，也持續改善了年輕、活躍患者的治療效果。

科技的融合正在加速進步。增強型顯像模式、計算建模和術中引導系統如今能夠實現精準的計畫和操作，從而減少治療結果的差異性。這些工具增強了治療複雜解剖結構的信心，並擴大了適合微創治療的患者群體。此外，對瓣膜耐久性和再干涉途徑管理的日益重視，也加強了開發支持分階段治療（包括瓣中瓣和混合治療）的設備平台的力度。

在商業性方面，設備創新者與成熟臨床網路之間的策略夥伴關係正在加速新技術的實用化。循證生成策略也在不斷發展，涵蓋了穩健的註冊和現場試驗，以記錄其在常規護理中的長期表現。總而言之，這些轉變正在創造一個更具競爭力、以證據主導的環境，其成功取決於能否證明臨床價值、簡化應用流程並確保患者的長期效益。

評估近期關稅變化將如何重塑整個心臟瓣膜設備生態系統的供應鏈、採購行為和策略製造決策

關稅狀況為整個心臟瓣膜設備生態系統的供應鏈設計、籌資策略和價格談判帶來了新的變數。關稅調整將影響進口零件和組裝設備的成本結構，促使製造商重新評估籌資策略，並考慮近岸外包、供應商多元化和垂直整合，以降低風險。這些應對措施將影響前置作業時間、庫存持有成本以及與醫療保健採購商的合約承諾。

臨床醫生的需求和醫院的採購週期會對總擁有成本的細微變化做出反應，尤其是在關稅引發的價格波動影響大批量生產中心常規使用的設備時。醫院和醫療系統可能會加強對採購決策的審查，要求更清晰的價值提案，並優先考慮能夠展現供應彈性和透明定價的供應商。同時，監管提交和競標流程可能需要更新成本效益文件，以反映投入成本的變化。

除了即時的採購效應外，關稅還可能加速供應商之間的策略整合，並引發生產能力的地理重新分配。對於新參與企業而言，關稅波動提升了生產彈性和本地臨床夥伴關係關係的策略重要性，從而支持其市場准入。同時，擁有多元化生產基地的現有企業可以利用其不斷擴大的規模和完善的物流系統來保持競爭優勢。整體而言，關稅動態增加了營運的複雜性，需要積極主動的情境規劃和敏捷的商業執行。

詳細的細分分析揭示了手術和經導管設備路徑、組織採購和修復方式如何定義臨床和商業性差異

對心臟瓣膜市場進行細分，可以揭示影響產品開發和商業化策略的不同技術路徑和臨床決策樹。就替代療法而言，市場分為外科手術和經導管兩種方法。外科手術瓣膜置換術術根據機械瓣膜和組織瓣膜的選擇而有所不同，組織瓣膜又進一步細分為同種異體移植瓣膜、支架瓣膜和非支架瓣膜。經導管人工瓣膜置換術透過專用輸送系統和解剖標靶引入了另一個細分維度，涵蓋經導管主動脈瓣置換術、經導管二尖瓣置換術和經導管肺動脈瓣置換術。

修復療法並行運作，但有類似的細微差別。外科修復包括瓣環狀成形術、腱索置換裝置和瓣膜再形成技術。瓣環狀成形術環依其柔韌性分為軟性、剛性和半剛性設計，腱索置換環狀成形術則包括自體心包重組和合成腱索置換。經導管修復領域已出現不同的系統類別，例如瓣環成形系統和瓣葉對合技術，例如夾子和瓣葉置換裝置。在環狀成形術系統中，商業性主流的方法包括經皮、解剖匹配的帶環和環圈解決方案。

了解這些細分路徑有助於明確臨床價值提案、監管證據需求和製造影響。例如，組織採購和加工會影響手術結構的耐久性，而輸送導管的設計和固定策略則決定了經導管平台的開發重點。同樣，修復和置換之間的差異會影響移植中心的報銷定位和培訓需求。因此，具備細分感知能力的策略能夠使開發人員和商業團隊將研發投資與手術實際情況和付款人的期望相協調。

區域採用模式和存取動態將決定監管機構、付款人和臨床基礎設施如何影響心臟瓣膜設備在全球市場上的商業化。

地理動態在心臟瓣膜技術的採用模式、監管途徑和商業模式中發揮著至關重要的作用。美洲地區擁有先進的介入基礎設施和強勁的臨床試驗活動，支援微創技術的快速應用和強大的上市後資料收集。歐洲、中東和非洲 (EMEA) 地區的監管和報銷格局各不相同，快速應用的市場與依賴集中採購和醫院預算限制的市場並存。

亞太地區的醫療保健體系成熟度參差不齊，一些市場在患者群體龐大和三級醫療能力提升的推動下，正快速普及。本地製造以及與區域臨床網路的合作正在加速一些亞太國家的醫療技術進入，而監管協調和基礎設施建設仍然是其他地區的重點。在整個地區，技能水平、臨床醫生培訓途徑以及公立和私人醫療服務模式的差異正在影響技術的採用和擴展方式。

區域洞察凸顯，一刀切的商業性模式無法帶來成效。成功的市場策略應預測當地監管要求，使臨床證據方案與當地付款人的期望一致，並根據移植中心的營運實際情況量身定做培訓和服務模式。跨境夥伴關係、本地臨床領導者以及靈活的交付模式是將創新轉化為持續在地應用的關鍵。

競爭與合作的動態，結合成熟的外科專業知識、敏捷的創新與策略夥伴關係，塑造市場領導地位

心臟瓣膜領域的競爭態勢反映出既有成熟的外科手術領導企業，也有專注於經導管和修復技術的敏捷創新者。成熟的外科手術器械製造商擁有規模、監管專業知識和長期臨床資料集等優勢，這些優勢支持其在注重耐用性和性能驗證的醫療中心的應用。這些公司通常利用涵蓋組織處理、人工替代物工程和全球分銷網路的全面產品組合來支持臨床教育和跨市場擴張。

同時，規模較小、更專注的公司正在推動顛覆性進步，他們專注於輸送系統、密封技術以及擴展微創方法的解剖相容性機制。這些公司經常與學術中心合作，以產生早期臨床證據，並透過迭代學習快速改進設備迭代。創新者與大型公司之間的策略聯盟和授權協議正變得越來越普遍，因為雙方都尋求互補的能力，例如生產規模、監管參與和上市執行。

服務和培訓生態系統也是一項關鍵的競爭優勢。提供強大的臨床醫生培訓、模擬和監考支援的供應商，能夠加速流程採用並降低結果的差異性，從而增強其商業性提案。隨著採用模式的轉變，那些將卓越技術與可擴展的臨床醫生支持和證據生成能力相結合的機構，將在臨床路徑領域佔據持久地位。

可行的建議，整合證據產生、供應鏈彈性、臨床醫生培訓和模組化技術設計，以加速採用和商業性成功

領導者應優先考慮整合策略，將臨床證據產生與可擴展的商業營運和彈性供應鏈結合。首先，投資一個強大的真實世界證據項目，透過記錄長期表現、患者報告結果以及在不同臨床環境下的比較有效性，補充關鍵臨床試驗。其次，透過多元化的供應商網路和區域生產能力，追求製造和採購的靈活性，以降低關稅和物流風險，同時保持品質和成本競爭力。

第三，我們將建立深入的臨床夥伴關係和培訓基礎設施，以促進安全應用，減少程序差異，並培養能夠在我們網路內清晰闡述我們設備價值的本地領導者。第四，我們將設計模組化平台和可互通的交付系統，以促進逐步護理並簡化醫院系統的庫存管理。模組化還能增強在不中斷既定流程的情況下迭代設備生命週期的能力。最後，為了滿足付款人的優先事項並展示長期價值，我們將採用能夠反映護理總成本的複雜定價策略，並在適當情況下支持基於結果的合約。

透過執行這些相互關聯的優先事項，行業領導者可以將技術進步轉化為永續的臨床應用和商業性成功，同時應對不斷變化的監管和付款人環境。

結合主要臨床醫生訪談、文獻綜合、設備路徑映射和供應鏈風險評估的透明調查方法支持可行的見解

本研究結合了透過對臨床醫生、設備工程師、監管專家和採購負責人進行結構化訪談收集的一手資料和二手資料，並輔以同行評審的臨床文獻和手術登記冊的分析。一手資料著重於對手術決策、設備選擇標準和實施障礙的定性洞察，而二手資料則提供有關技術趨勢、監管先例和不斷發展的臨床指南的背景資訊。調查方法優先考慮跨輸入類型的三角測量，以確保主題結論的穩健性，並減輕與單一資訊來源觀點相關的偏差。

分析方法包括器械路徑圖、臨床結果三角測量和供應鏈風險評估。器械路徑圖將設計屬性與程序工作流程和培訓需求連結起來，而結果三角測量則將早期臨床報告與註冊資料進行比較，以識別一致的績效訊號。供應鏈評估評估了採購強度、物流依賴性以及潛在關稅對成本和前置作業時間的影響。在可能的情況下，透過與專家的後續討論來檢驗研究結果，以完善解釋並檢驗方案。

因此，相關人員可以將洞察直接應用於策略規劃、產品開發優先排序和上市排序。方法的透明度支援可重複性，允許客戶根據需要請求更深入地研究特定的細分市場或區域。

關於綜合證據、營運彈性和策略性商業化如何定義心臟瓣膜護理的長期領導地位的最終觀點

心臟瓣膜修復與置換領域正邁入更微妙的時代，器械創新、臨床證據和系統層面的經濟效益將共同決定哪些技術能夠成功。隨著經導管技術的擴展和外科人工替代物的不斷發展，耐久性、再次介入途徑和以患者為中心的治療結果之間的相互作用將日益影響治療方案的選擇。能夠整合嚴謹的證據產生、敏捷的製造和有針對性的區域策略的相關人員將最有能力影響臨床實踐並獲得長期價值。

營運彈性和有計劃的商業化方法比以往任何時候都更加重要。關稅趨勢和供應鏈的複雜性需要積極規劃，而競爭差異化則取決於能否展現出與臨床醫生、付款人和醫療系統領導者產生共鳴的真正優勢。投資於臨床醫生培訓、可擴展服務模式和模組化設備平台的公司將降低採用門檻，並支持更廣泛的應用。

最終，該領域的持續領導地位將來自於那些在科學嚴謹性與商業性實用性之間取得平衡的公司，他們的產品策略以可證明的患者利益為中心，同時確保後勤和經濟方面的考慮支持可靠且負擔得起的醫療保健服務。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 錨固型經導管二尖瓣置換系統在重度逆流患者的應用
  • 3D列印和整合的患者專用心臟瓣膜支架，實現個人化修復效果
  • 引入微創機器人輔助主動脈瓣置換術以縮短住院時間
  • 開發用於減少血栓症的下一代經導管心臟瓣膜的可吸收聚合物瓣膜
  • 透過提高即時血流動力學監測感測器的利用率來最佳化人工心臟瓣膜的性能
  • 擴大瓣中瓣手術適應症，適用於有功能障礙的生物瓣膜的高風險手術患者
  • 經皮三尖瓣修復裝置在老年功能性三尖瓣逆流患者的應用

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 心臟瓣膜修復置換設備市場置換設備

  • 手術置換
    • 機械閥
    • 組織瓣膜
      • 同種異體移植
      • 組織瓣膜瓣膜
      • 牛
      • 豬肉瓣
      • 無支架組織瓣膜
  • 經導管置換術
    • 塔武爾
    • 湯姆·巴爾
    • 輕敲

9. 心臟瓣膜修復置換設備市場修復設備

  • 手術修復
    • 環狀成形術環
      • 軟性環
      • 剛性環
      • 半剛性環
    • 和弦替換裝置
      • 自體心包索
      • 合成繩
    • 瓣環成形裝置
  • 經導管修復
    • 環狀成形術系統
      • 有氧運動帶
      • 二尖瓣環折疊術
    • 二尖瓣夾系統
    • 帕斯卡系統

10. 心臟瓣膜修復和置換設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 11 章。心臟瓣膜修復和置換設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

12. 心臟瓣膜修復和置換設備市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第13章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Terumo Corporation
    • MicroPort Scientific Corporation
Product Code: MRR-925E8149CC89

The Heart Valve Repair & Replacement Devices Market is projected to grow by USD 12.70 billion at a CAGR of 8.44% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.64 billion
Estimated Year [2025] USD 7.20 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 8.44%

A comprehensive introduction to the evolving clinical, technological, and commercial dynamics reshaping heart valve repair and replacement pathways

The field of heart valve repair and replacement stands at a pivotal inflection point where surgical tradition intersects with rapid transcatheter innovation. Advances in imaging, device design, and perioperative management have progressively shifted clinical decision-making pathways, expanding therapeutic options for patients across risk spectra. This evolution reflects broader changes in cardiovascular care, including multidisciplinary heart teams, refined patient selection criteria, and a stronger emphasis on long-term valve performance and quality of life.

Clinicians and health systems now evaluate valve interventions not only through the lens of acute procedural success but also by durability, need for reintervention, and implications for future transcatheter access. As a result, technology developers and device manufacturers are prioritizing modularity, ease of deployment, and compatibility with valve-in-valve strategies. Concurrently, regulatory authorities and payers are increasingly focused on real-world evidence and comparative effectiveness, shaping the pathway for commercialization and reimbursement.

Taken together, these elements create a dynamic landscape in which clinical needs, technological capability, and commercial imperatives interact. Stakeholders that understand these dynamics and align product development, clinical evidence generation, and market access strategies will be best positioned to influence care pathways and capture opportunities arising from the shifting treatment paradigm.

How clinical innovation, imaging advances, and evidence-driven commercialization are collectively transforming heart valve treatment modalities and care pathways

Recent years have delivered transformative shifts that extend beyond incremental device improvements to alter how clinicians approach valve disease entirely. Minimally invasive transcatheter techniques have matured from niche options to mainstream therapies for certain patient groups, driven by improvements in delivery systems, sealing mechanisms, and device profiles that reduce procedural trauma and recovery time. At the same time, refinements in surgical prostheses, including tissue processing and hemodynamic optimization, continue to elevate performance for younger and more active patients.

Technology convergence has accelerated progress. Enhanced imaging modalities, computational modeling, and intra-procedural guidance systems now enable precision planning and device placement that reduce variability in outcomes. These tools foster higher confidence in treating complex anatomies, which expands the population eligible for less invasive approaches. Furthermore, the emphasis on valve durability and the management of reintervention pathways has intensified efforts to develop device platforms that support staged therapies, including valve-in-valve or hybrid approaches.

On the commercial front, strategic partnerships between device innovators and established clinical networks expedite the translation of new technologies into practice. Evidence generation strategies have evolved to include robust registries and pragmatic trials that capture longitudinal performance in routine care. Collectively, these shifts create a more competitive, evidence-driven environment where the ability to demonstrate clinical value, streamline adoption, and ensure long-term patient benefit determines success.

Assessing how recent tariff changes reshape supply chains, procurement behavior, and strategic manufacturing decisions across the heart valve device ecosystem

The tariff landscape has introduced new variables for supply chain design, procurement strategies, and pricing negotiations across the heart valve device ecosystem. Tariff adjustments influence cost structures for imported components and assembled devices, prompting manufacturers to reassess sourcing strategies and consider nearshoring, supplier diversification, or vertical integration to mitigate exposure. These responses have implications for lead times, inventory carrying costs, and contractual commitments with healthcare purchasers.

Clinician demand and hospital purchasing cycles respond to subtle shifts in total cost of ownership, particularly when tariff-induced price changes affect devices used routinely in high-volume centers. Hospitals and health systems may increase scrutiny of procurement decisions, demand clearer value propositions, and prioritize vendors that can demonstrate supply resilience and transparent pricing. In parallel, regulatory submissions and tender processes may require updated cost-effectiveness documentation that reflects changed input costs.

Beyond immediate procurement effects, tariffs can accelerate strategic consolidation among suppliers and trigger geographic repositioning of manufacturing capacity. For newer entrants, tariff volatility elevates the strategic importance of manufacturing flexibility and local clinical partnerships to support market entry. Meanwhile, established incumbents with diversified production footprints can leverage scale and logistics sophistication to maintain competitive advantage. Overall, tariff dynamics add a layer of operational complexity that requires proactive scenario planning and agile commercial execution.

Deep segmentation analysis revealing how surgical and transcatheter device pathways, tissue sourcing, and repair modalities define clinical and commercial differentiation

Segmenting the heart valve market illuminates distinct technology pathways and clinical decision trees that influence product development and commercialization strategies. When considering replacement therapies, the market divides into surgical and transcatheter approaches. Surgical replacement remains differentiated by mechanical and tissue valve options, with tissue valves further subdivided into homografts, stented and stentless designs; stented constructs commonly draw on bovine pericardial and porcine tissue sources. Transcatheter replacement introduces another axis of segmentation through dedicated delivery systems and anatomic targets, covering transcatheter aortic replacement, transcatheter mitral replacement, and transcatheter pulmonary replacement systems, each with unique device design constraints and clinical endpoints.

Repair therapies constitute a parallel but equally nuanced landscape. Surgical repair includes annuloplasty rings, chordal replacement devices, and valve reshaping technologies, where annuloplasty rings are themselves classified by flexibility characteristics into flexible, rigid, and semi-rigid designs, and chordal replacement options range from autologous pericardial reconstructions to synthetic chordae. The transcatheter repair domain has emerged with distinct system classes such as annuloplasty systems and leaflet approximation technologies like clip and alternative leaflet devices; within annuloplasty systems, commercially prominent approaches include band and loop-like solutions tailored to percutaneous anatomy.

Understanding these segmentation pathways clarifies clinical value propositions, regulatory evidence needs, and manufacturing implications. For example, tissue sourcing and processing impact durability narratives for surgical constructs, while delivery catheter design and anchoring strategies drive development priorities for transcatheter platforms. Similarly, the distinctions between repair and replacement inform reimbursement positioning and training requirements for implanting centers. Segment-aware strategies therefore enable developers and commercial teams to align R&D investments with procedural realities and payer expectations.

Regional adoption patterns and access dynamics that determine how regulatory, payer, and clinical infrastructures shape heart valve device commercialization across global markets

Geographic dynamics play a decisive role in adoption patterns, regulatory pathways, and commercial models for heart valve technologies. The Americas exhibit advanced interventional infrastructure and strong clinical trial activity, supporting rapid uptake of minimally invasive techniques and robust post-market data collection; payers in this region increasingly seek evidence of long-term value and comparative effectiveness when evaluating new devices. Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape where high-adoption pockets coexist with markets that depend on centralized procurement and constrained hospital budgets; pricing strategies and health technology assessment outcomes strongly influence market access timelines across this region.

Asia-Pacific demonstrates diverse maturity across national health systems, with several markets showing rapid adoption driven by large patient populations and growing capacities in tertiary centers. In some countries within Asia-Pacific, local manufacturing and partnerships with regional clinical networks accelerate entry, while in others, regulatory harmonization and infrastructure build-out remain focal areas. Across all regions, differences in procedural volumes, clinician training pathways, and public versus private healthcare delivery models shape how technologies are introduced and scaled.

Regional insights underscore that a one-size-fits-all commercial approach will underdeliver. Instead, successful market strategies anticipate local regulatory requirements, adapt clinical evidence packages to regional payer expectations, and tailor training and service models to the operational realities of implanting centers. Cross-border partnerships, local clinical champions, and flexible supply models are instrumental in translating innovation into sustained regional adoption.

Competitive and collaborative dynamics that combine established surgical prowess with nimble innovation and strategic partnerships to shape market leadership

Competitive dynamics in the heart valve space reflect a mix of long-established surgical leaders and agile innovators focused on transcatheter and repair technologies. Incumbent surgical device manufacturers maintain strengths in scale, regulatory expertise, and long-term clinical datasets that underpin adoption in centers where durability and proven performance remain primary considerations. These organizations often leverage comprehensive portfolios that span tissue processing, prosthesis engineering, and global distribution networks to support clinical education and multi-market rollouts.

At the same time, smaller and more focused companies drive disruptive progress by concentrating on delivery systems, sealing technologies, and mechanisms that expand anatomical suitability for less invasive approaches. These firms frequently collaborate with academic centers to generate early clinical evidence and refine device iterations quickly through iterative learning. Strategic alliances and licensing agreements between innovators and larger firms are common as each side seeks complementary capabilities, whether in manufacturing scale, regulatory navigation, or market access execution.

Service and training ecosystems are also pivotal competitive assets. Providers who offer robust clinician training, simulation, and proctoring support accelerate procedural adoption and reduce variability in outcomes, thereby enhancing the commercial proposition. As adoption patterns shift, organizations that combine technical excellence with scalable clinician support and evidence generation capabilities will secure durable positions in clinical pathways.

Actionable recommendations that integrate evidence generation, supply chain resilience, clinician training, and modular technology design to accelerate adoption and commercial success

Leaders should prioritize integrated strategies that align clinical evidence generation with scalable commercial operations and resilient supply chains. First, invest in robust, real-world evidence programs that complement pivotal trials by documenting long-term performance, patient-reported outcomes, and comparative effectiveness in diverse clinical settings; such evidence underpins payer dialogues and supports favorable reimbursement pathways. Second, pursue manufacturing and sourcing flexibility through diversified supplier networks and regional production capacities to mitigate tariff and logistics risks while preserving quality and cost competitiveness.

Third, cultivate deep clinical partnerships and training infrastructure to accelerate safe adoption, reduce procedural variability, and foster local champions who can articulate device value within their networks. Fourth, design modular platforms and interoperable delivery systems that facilitate staged therapies and simplify inventory management for hospital systems; modularity also enhances the ability to iterate device lifecycles without disrupting established procedural workflows. Finally, adopt sophisticated pricing strategies that reflect total cost of care implications and support outcomes-based contracting where appropriate to address payer priorities and demonstrate value over time.

By executing on these interconnected priorities, industry leaders can convert technical advances into sustainable clinical adoption and commercial success while remaining responsive to evolving regulatory and payer environments.

Transparent research methodology combining primary clinician interviews, literature synthesis, device pathway mapping, and supply chain risk assessment to support actionable insights

This research synthesizes primary and secondary evidence gathered through structured interviews with clinicians, device engineers, regulatory specialists, and procurement leaders, supplemented by analysis of peer-reviewed clinical literature and procedural registries. Primary research emphasized qualitative insights into procedural decision-making, device selection criteria, and adoption barriers, while secondary sources provided context on technological trends, regulatory precedents, and clinical guideline evolution. The methodology prioritized triangulation across input types to ensure the robustness of thematic conclusions and to reduce bias associated with single-source perspectives.

Analytical approaches included device pathway mapping, clinical outcome triangulation, and supply chain risk assessment. Device pathway mapping linked design attributes to procedural workflows and training needs, whereas outcome triangulation compared early clinical reports with registry data to identify consistent performance signals. Supply chain assessments evaluated sourcing concentration, logistics dependencies, and potential tariff impacts on cost and lead time. Wherever possible, findings were validated through follow-up discussions with domain experts to refine interpretation and test scenario plausibility.

The resulting synthesis focuses on actionable implications rather than predictive estimates, enabling stakeholders to apply insights directly to strategic planning, product development prioritization, and market entry sequencing. Transparency in methods supports reproducibility and allows clients to request deeper dives into specific segments or geographies as needed.

Concluding perspective on how integrated evidence, operational resilience, and strategic commercialization will define long-term leadership in heart valve therapies

The heart valve repair and replacement domain is transitioning to a more nuanced era where device innovation, clinical evidence, and system-level economics jointly determine which technologies succeed. As transcatheter techniques expand and surgical prostheses continue to evolve, the interplay between durability, reintervention pathways, and patient-centered outcomes will increasingly drive therapeutic choices. Stakeholders who integrate rigorous evidence generation with agile manufacturing and targeted regional strategies will be best positioned to influence clinical practice and capture long-term value.

Operational resilience and deliberate commercialization approaches matter now more than ever. Tariff dynamics and supply chain complexities require proactive planning, while competitive differentiation depends on demonstrating real-world benefits that resonate with clinicians, payers, and health system leaders. Companies that invest in clinician training, scalable service models, and modular device platforms will reduce barriers to adoption and support broader procedural diffusion.

Ultimately, sustained leadership in this space will come from organizations that balance scientific rigor with commercial pragmatism, anchoring product strategies in demonstrable patient benefit while ensuring that logistical and economic considerations support reliable, affordable access to care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of transcatheter mitral valve replacement systems with enhanced anchoring in patients with severe regurgitation
  • 5.2. Integration of 3D printed patient specific heart valve scaffolds for personalized repair outcomes
  • 5.3. Adoption of minimally invasive robotic assisted aortic valve replacement techniques to reduce hospital stays
  • 5.4. Development of resorbable polymeric leaflets for next generation transcatheter heart valves with reduced thrombosis
  • 5.5. Increased utilization of real time hemodynamic monitoring sensors in prosthetic heart valves for performance optimization
  • 5.6. Expanding indications for valve in valve procedures in high risk surgical candidates with failing bioprostheses
  • 5.7. Growth of percutaneous tricuspid valve repair devices targeting functional tricuspid regurgitation in elderly patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Repair & Replacement Devices Market, by Replacement Devices

  • 8.1. Surgical Replacement
    • 8.1.1. Mechanical Valves
    • 8.1.2. Tissue Valves
      • 8.1.2.1. Homografts
      • 8.1.2.2. Stented Tissue Valves
      • 8.1.2.2.1. Bovine Pericardial Valves
      • 8.1.2.2.2. Porcine Valves
      • 8.1.2.3. Stentless Tissue Valves
  • 8.2. Transcatheter Replacement
    • 8.2.1. Tavr
    • 8.2.2. Tmvr
    • 8.2.3. Tpvr

9. Heart Valve Repair & Replacement Devices Market, by Repair Devices

  • 9.1. Surgical Repair
    • 9.1.1. Annuloplasty Rings
      • 9.1.1.1. Flexible Rings
      • 9.1.1.2. Rigid Rings
      • 9.1.1.3. Semi-Rigid Rings
    • 9.1.2. Chordal Replacement Devices
      • 9.1.2.1. Autologous Pericardial Chordae
      • 9.1.2.2. Synthetic Chordae
    • 9.1.3. Valve Reshaping Devices
  • 9.2. Transcatheter Repair
    • 9.2.1. Annuloplasty Systems
      • 9.2.1.1. Cardioband
      • 9.2.1.2. Mitral Loop Cerclage
    • 9.2.2. Mitral Clip Systems
    • 9.2.3. PASCAL Systems

10. Heart Valve Repair & Replacement Devices Market, by Region

  • 10.1. Americas
    • 10.1.1. North America
    • 10.1.2. Latin America
  • 10.2. Europe, Middle East & Africa
    • 10.2.1. Europe
    • 10.2.2. Middle East
    • 10.2.3. Africa
  • 10.3. Asia-Pacific

11. Heart Valve Repair & Replacement Devices Market, by Group

  • 11.1. ASEAN
  • 11.2. GCC
  • 11.3. European Union
  • 11.4. BRICS
  • 11.5. G7
  • 11.6. NATO

12. Heart Valve Repair & Replacement Devices Market, by Country

  • 12.1. United States
  • 12.2. Canada
  • 12.3. Mexico
  • 12.4. Brazil
  • 12.5. United Kingdom
  • 12.6. Germany
  • 12.7. France
  • 12.8. Russia
  • 12.9. Italy
  • 12.10. Spain
  • 12.11. China
  • 12.12. India
  • 12.13. Japan
  • 12.14. Australia
  • 12.15. South Korea

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Analysis
    • 13.3.1. Edwards Lifesciences Corporation
    • 13.3.2. Medtronic plc
    • 13.3.3. Abbott Laboratories
    • 13.3.4. Boston Scientific Corporation
    • 13.3.5. LivaNova PLC
    • 13.3.6. CryoLife, Inc.
    • 13.3.7. Terumo Corporation
    • 13.3.8. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 7. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY